Chinese EN

Tedizolid Phosphate

Tedizolid Phosphate

【Chemical Name】Tedizolid Phosphate
【Original】Cubist、Bayer
【Time to market】2014.06.20
【Patents expire】2024.12.16
【Dosage and Usage】Tablet: 200 mg,For injection: 200 mg, used for the treatment

  of acute bacterial skin and skin structural infection (ABSSSI) caused by sensitive bacteria.



 

Tedizolid Phosphate


一、 Product Overview

Tedizolid Phosphate, an antibiotic developed by Cubist pharmaceuticals, USA, for the treatment of bacterial skin and skin structure infection, was approved by FDA on June 20, 2014, and the patent date of the compound expired on December 16, 2024.


二、Main products

Description

Structural Formula

CAS No.

Category

Tedizolid Phosphate

856867-55-5.bmp

856867-55-5

API

(R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridine-5-yl)-3-fluorophenyl)-5-hydroxymethyl   oxazolidin-2-one

MS1023-03 856866-72-3.bmp

856866-72-3

intermediates

5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine

MS1023-04 380380-64-3.bmp

380380-64-3

intermediates

(R)-3-(4-bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one

MS1023-06  444335-16-4.bmp

444335-16-4

intermediates

(R)-3-(3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one

MS1023-11 149524-42-5.bmp

149524-42-5

intermediates

2-(2-methyl-2H-tetrazol-5-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

MS1023-09 1056039-83-8.bmp

1056039-83-8

intermediates

Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk.